Insider Transactions in Q4 2020 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2020
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-45.93%
|
$330,000
$22.97 P/Share
|
|
Dec 01
2020
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+31.47%
|
$105,000
$7.2 P/Share
|
|
Nov 23
2020
|
Peter Ordentlich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,972
-50.57%
|
$689,356
$23.27 P/Share
|
|
Nov 23
2020
|
Peter Ordentlich Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,972
+32.97%
|
$89,916
$3.08 P/Share
|
|
Nov 10
2020
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
17,466
-27.28%
|
$349,320
$20.06 P/Share
|
|
Nov 10
2020
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
17,466
+21.43%
|
$122,262
$7.2 P/Share
|
|
Nov 09
2020
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
62,938
-57.48%
|
$1,258,760
$20.04 P/Share
|
|
Nov 09
2020
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
62,938
+36.5%
|
$440,566
$7.2 P/Share
|
|
Nov 04
2020
|
Michael A Metzger Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-84.99%
|
$2,000,000
$20.31 P/Share
|
|
Nov 04
2020
|
Michael A Metzger Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+45.94%
|
$700,000
$7.2 P/Share
|